Regulated Funding Surpass holds NIH OLAW assurance and a DOD safety plan, signaling readiness to undertake government-funded preclinical studies and compete for regulated research contracts.

Device Focus Deep expertise across medical devices, pharma, biotech and combination products with surgical and interventional procedures, offering early feasibility, GLP studies and cadaver work for rigorous device evaluation.

End-to-End Partner Provides end-to-end preclinical services from study design and model selection to protocol development, experimental surgery, device performance assessment, human factors and reporting, enabling outsourcing or co-development.

Regional Advantage Midwest based with AAALAC accredited facilities and hospital-grade equipment, offering scalable surgical suites and timely execution for regional medical technology companies.

Growth and Credibility Industry recognition for quality and regulatory excellence, plus historic capacity expansion through strategic acquisition, signaling credibility and potential to handle larger or more complex programs.